JS001
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of the Combination of Anlotinib and JS001 in EGFR-TKI Resistant T790M-Negative NSCLC (NCT04116918) | Baodong Qin | 2019-09-01 |
Track JS001 automatically
Every clearance here is in the API, with alerts when new ones post.